fda glp-1 warning october 2025 GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Agonists Societies take stand against off-brand
Description
US Letter size + A4
Yes, headache is recognised as a potential side effect of GLP-1 receptor agonists , though it occurs less frequently than gastrointestinal symptoms
Gut-Support Strategies During GLP-1 Use 1
General tips for any switch Track everything during the transition
A researcher on a 4mg weekly protocol who splits into three injections is taking approximately 1.33mg per injection
In 2025, the court allowed central failure-to-warn claims to proceed but adopted strict proof standards, requiring plaintiffs to provide objective diagnostic evidence confirming gastric injury
